Interdisciplinary multimodality management of stage III nonsmall cell lung cancer
Stage III nonsmall cell lung cancer (NSCLC) comprises about one-third of NSCLC patients and is very heterogeneous with varying and mostly poor prognosis. It is also called “locoregionally or locally advanced disease”. Due to its heterogeneity a general schematic management approach is not appropriat...
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
European Respiratory Society
2019-07-01
|
| Series: | European Respiratory Review |
| Online Access: | http://err.ersjournals.com/content/28/152/190024.full |